Delivery Order SPE2DB24D2205-SPE2DB24FDYLQ

Award Date 8/14/24
Potential Completion Date 8/15/24
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the delivery of REVATIO 20 MG TABLET 90S. The contract has a ceiling value of $11,813.78 and an ultimate completion date of September 11, 2024. It is a delivery order contract under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA Troop Support Medical to efficiently procure...
This is a $25,632.77 firm fixed-price delivery order contract for REVATIO 20 MG TABLET 90S, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $7,729.32, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REVATIO 20 MG TABLET 90S, a pharmaceutical product used to treat certain medical conditions. The contract has an ultimate completion date of July 10, 2024 and is a Firm Fixed Price Delivery Order. There was no set-aside designation used for this award....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of REVATIO 20 MG TABLET 90S. The contract has a ceiling value of $18,035.96 and an ultimate completion date of September 5, 2024. The order is a firm-fixed price contract, indicating a pre-determined price for the goods. AmerisourceBergen has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by various...
This federal contract award, valued at $9,375.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REVATIO 20 MG TABLET 90S, a pharmaceutical product. This award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award, with ID SPE2DB24D2205|SPE2DB24FDVWT, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,966.52, is for the delivery of REVATIO 20 MG TABLET 90S, a medication used to treat pulmonary arterial hypertension. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an Ultimate Completion Date of June 24, 2024....
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of REVATIO 20 MG TABLET 90S, a pharmaceutical product. The contract has a ceiling value of $22,850.43 and a completion date of July 3, 2024. It was awarded on a Firm Fixed Price basis by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The award is a Delivery Order placed against Amerisourcebergen's existing Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $40,367.70 delivery order contract is for the supply of REVATIO 20 MG TABLET 90S, a pharmaceutical product. The contract is a Firm Fixed Price arrangement with a period of performance ending on May 31, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $17,154.07 with a ceiling of $17,154.07. The award was made by the Defense Logistics Agency (DLA), a defense agency, and is for the provision of the pharmaceutical product REVATIO 20 MG TABLET 90S. The contract is a Firm Fixed Price arrangement with a period of performance running through June 10, 2024. This award is part of a larger Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of REVATIO 20 MG TABLET 90S. The contract has a ceiling value of $4,662.96 and an ultimate completion date of September 20, 2024. The award is not associated with a set-aside program. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies, enabling the efficient procurement of a wide range of...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDYLQ
    Delivery Order

This federal contract award is for the delivery of the pharmaceutical product REVATIO 20 MG TABLET 90S to the Defense Logistics Agency (DLA). The $14,696.91 firm fixed price contract was awarded to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical and medical products to the U.S. government. The contract has an ultimate completion date of August 15, 2024. This appears to be a one-time delivery order under a larger indefinite delivery contract (IDC) held by AmerisourceBergen with the DLA, valued at up to $999,999,999 through December 2025, for the comprehensive supply of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 11/13/24, 9:11 AM